Please view this video or read on so that we can raise awareness about an upcoming FDA decision that will affect thousands of metastatic breast cancer survivors.
Avastin is an anticancer medication that many metastatic breast cancer patients respond to. As we move towards personalized medicine, we need better ways to evaluate who will and will not respond to a medication and assure that those medications that benefit subsets of the population remain available.
Both Komen for the Cure and the Ovarian Cancer National Alliance’s statement about this topi can be viewed at :http://ww5.komen.org/KomenNewsArticle.aspx?id=6442452367. The FDA decision on the drug Avastin was scheduled to occur on December 16, but has been postponed for the time being, so we have some time to act, but not much.